Physician profile
Srinivas S Atri
NPI 1669434460
$4,936.26
in general payments reported to CMS, 2019-2025
35 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,112 · 2020: $563 · 2021: $603 · 2022: $818 · 2023: $834 · 2024: $550 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,807 · Education: $32.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,807.19 |
| Education | $32.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $673.24 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $657.48 | 2019-2025 | |
| Boston Scientific Corporation | $422.91 | 2019-2025 | Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $414.79 | 2019-2023 | Farxiga, Wainua |
| Merck Sharp & Dohme LLC | $371.82 | 2021-2023 | Verquvo |
| Novo Nordisk INC | $310.49 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $256.01 | 2019-2024 | Camzyos |
| Pfizer INC. | $218.38 | 2019-2024 | |
| Amgen INC. | $207.75 | 2019-2025 | Repatha |
| Akcea Therapeutics, INC. | $156.13 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.39 | 2019-2023 | Lifevest |
| Abbott Laboratories | $106.50 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Amarin Pharma, INC. | $99.98 | 2019-2021 | |
| Daiichi Sankyo INC. | $90.28 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.50 | 2020-2025 | Jardiance |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $65.02 | 2022-2024 | (Ck4) Mcot |
| Alnylam Pharmaceuticals INC. | $64.92 | 2024-2025 | Amvuttra, Onpattro |
| Biosense Webster, INC. | $60.01 | 2022 | |
| Sanofi-Aventis U.S. LLC | $59.14 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $58.56 | 2023 | Arcalyst |
| Bardy Diagnostics, INC. | $52.00 | 2020-2022 | |
| Baxter Healthcare | $48.96 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Inspire Medical Systems, INC. | $48.63 | 2023-2024 | Inspire |
| Kiniksa Pharmaceuticals International, Plc | $35.40 | 2024 | Arcalyst |
| Atricure, INC. | $34.60 | 2019 | |
| Medtronic, INC. | $28.74 | 2025 | Symplicity G3 |
| Kestra Medical Technology Services, INC. | $28.64 | 2025 | Assure Wcd |
| Gilead Sciences, INC. | $27.42 | 2019 | |
| Glaxosmithkline, LLC. | $25.00 | 2025 | Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $21.15 | 2021 | |
| Edwards Lifesciences Corporation | $19.88 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $18.87 | 2023 | Inpefa |
| G Medical Diagnostic Services, INC. | $14.77 | 2023 | Cardiac Monitoring Suite |
| Acarix USA INC. | $14.49 | 2023 | Cadscor System |
| Kowa Pharmaceuticals America, INC. | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinivas Atri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.